pCPA Activity Overview

Status Total Negotiations Summary
Active Negotiations 28 Non-oncology: 18
Oncology: 10
Under Consideration for Negotiation 24 Non-oncology: 17
Oncology: 7
Completed Negotiations 381 With Letter of Intent: 328
Without agreement: 53
Negotiations That Were Not Pursued 77

pCPA Activity in the last four weeks

Activity for the last four weeks. Please note that these updates may take one to two weeks to be processed.

Engagement Letters Issued in the last four weeks

Brand Name Manufacturer Indication Engagement Date
No engagement letters issued in the last four weeks

Negotiations Completed in the last four weeks with a Letter of Intent

Brand Name Manufacturer Indication Engagement Date Close Date
No negotiations completed with a letter of intent in the last four weeks

Negotiations Completed in the last four weeks without Agreement

Brand Name Manufacturer Indication Engagement Date Close Date
No negotiations completed without agreement in the last four weeks

Negotiations that pCPA Decided Not to Pursue in the last four weeks

Brand Name Manufacturer Indication Close Date
Tecentriq & Avastin HOFFMANN-LA ROCHE LIMITED Non-Squamous Non-Small Cell Lung Cancer